Day One Biopharmaceuticals, Inc.DAWNNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+218.8%
5Y CAGR+156.5%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+218.8%/yr
Annual compound
5Y CAGR
+156.5%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
111x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $17.21M | +226.0% |
| 2024 | $5.28M | +1278.3% |
| 2023 | $383000.00 | -27.9% |
| 2022 | $531000.00 | +166.8% |
| 2021 | $199000.00 | +28.4% |
| 2020 | $155000.00 | - |
| 2019 | $0.00 | - |